Item Details

The Economics of Genomic Medicine [electronic resource]: Workshop Summary

Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine; Ebook Central - Academic Complete
Format
EBook; Book; Online
Published
Washington : National Academies Press July 2013
Language
English
ISBN
9780309269681, 0309269687 (Trade Paper)
Target Audience
Scholarly & Professional
Summary
Annotation
Description
Mode of access: World wide Web.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Access in Virgo Classic

  • LEADER 03827cam a22003612 4500
    001 u6335727
    003 SIRSI
    005 20170608061650.0
    006 m d
    007 cr n
    008 130419e20130704dcu s|||||||| 2|eng|d
    020
      
      
    a| 9780309269681
    020
      
      
    a| 0309269687 (Trade Paper) c| USD 42.00 Retail Price (Publisher) 9| Active Record
    035
      
      
    a| (WaSeSS)ssj0001214062
    037
      
      
    b| 00017961
    040
      
      
    a| BIP US d| WaSeSS
    110
    2
      
    a| Roundtable on Translating Genomic-Based Research for Health e| Author
    245
    1
    4
    a| The Economics of Genomic Medicine h| [electronic resource]: b| Workshop Summary
    260
      
      
    a| Washington : b| National Academies Press c| July 2013
    520
    8
      
    a| Annotation b| The sequencing of the human genome and the identification of links between specific genetic variants and diseases have led to tremendous excitement over the potential of genomics to direct patient treatment toward more effective or less harmful interventions. Still, the use of whole genome sequencing challenges the traditional model of medical care where a test is ordered only when there is a clear indication for its use and a path for downstream clinical action is known. This has created a tension between experts who contend that using this information is premature and those who believe that having such information will empower health care providers and patients to make proactive decisions regarding lifestyle and treatment options.In addition, some stakeholders are concerned that genomic technologies will add costs to the health care system without providing commensurate benefits, and others think that health care costs could be reduced by identifying unnecessary or ineffective treatments. Economic models are frequently used to anticipate the costs and benefits of new health care technologies, policies, and regulations. Economic studies also have been used to examine much more specific issues, such as comparing the outcomes and cost effectiveness of two different drug treatments for the same condition. These kinds of analyses offer more than just predictions of future health care costs. They provide information that is valuable when implementing and using new technologies. Unfortunately, however, these economic assessments are often limited by a lack of data on which to base the examination. This particularly affects health economics, which includes many factors for which current methods are inadequate for assessing, such as personal utility, social utility, and patient preference.To understand better the health economic issues that may arise in the course of integrating genomic data into health care, the Roundtable on Translating Genomic-Based Research for Health hosted a workshop in Washington, DC, on July 17-18, 2012, that brought together economists, regulators, payers, biomedical researchers, patients, providers, and other stakeholders to discuss the many factors that may influence this implementation. The workshop was one of a series that the roundtable has held on this topic, but it was the first focused specifically on economic issues. The Economics of Genomic Medicine summarizes this workshop.
    521
      
      
    a| Scholarly & Professional b| National Academies Press
    538
      
      
    a| Mode of access: World wide Web.
    655
      
    0
    a| Electronic books.
    690
      
      
    a| Genomics
    692
      
      
    a| Science x| Life Sciences x| Genetics & Genomics
    710
    1
      
    a| Board on Health Sciences Policy.
    710
    1
      
    a| Institute of Medicine.
    710
    2
      
    a| Ebook Central - Academic Complete
    710
    2
      
    a| National Academies Press Free eBooks
    856
    4
    0
    u| http://RE5QY4SB7X.search.serialssolutions.com/?V=1.0&L=RE5QY4SB7X&S=JCs&C=TC0001214062&T=marc
    596
      
      
    a| 1
    999
      
      
    a| XX(6335727.1) w| WEB i| 6335727-1001 l| INTERNET m| UVA-LIB t| INTERNET

Availability

Google Preview

Read Online